Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Oct;70(828):746–748. doi: 10.1136/pgmj.70.828.746

A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis.

N Robin 1, G Gill 1, C van Heyningen 1, W Fraser 1
PMCID: PMC2397778  PMID: 7831175

Abstract

A patient is described with small cell carcinoma of the lung, associated with profound hypophosphataemia and hyponatraemia. Increased phosphate excretion and inappropriately high urine osmolality were observed. The abnormalities are consistent with tumoral hypophosphataemia and inappropriate antidiuresis. These tumour-related metabolic abnormalities have only been described once before with this malignancy.

Full text

PDF
746

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartter F. C., Schwartz W. B. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967 May;42(5):790–806. doi: 10.1016/0002-9343(67)90096-4. [DOI] [PubMed] [Google Scholar]
  2. Cai Q., Hodgson S. F., Kao P. C., Lennon V. A., Klee G. G., Zinsmiester A. R., Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med. 1994 Jun 9;330(23):1645–1649. doi: 10.1056/NEJM199406093302304. [DOI] [PubMed] [Google Scholar]
  3. Daniels R. A., Weisenfeld I. Tumorous phosphaturic osteomalacia. Report of a case associated with multiple hemangiomas of bone. Am J Med. 1979 Jul;67(1):155–159. doi: 10.1016/0002-9343(79)90097-4. [DOI] [PubMed] [Google Scholar]
  4. Harvey J. N., Gray C., Belchetz P. E. Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf) 1992 Oct;37(4):379–382. doi: 10.1111/j.1365-2265.1992.tb02342.x. [DOI] [PubMed] [Google Scholar]
  5. Hewison M., Karmali R., O'Riordan J. L. Tumour induced osteomalacia. Clin Endocrinol (Oxf) 1992 Oct;37(4):382–384. doi: 10.1111/j.1365-2265.1992.tb02343.x. [DOI] [PubMed] [Google Scholar]
  6. Lyles K. W., Berry W. R., Haussler M., Harrelson J. M., Drezner M. K. Hypophosphatemic osteomalacia: association with prostatic carcinoma. Ann Intern Med. 1980 Aug;93(2):275–278. doi: 10.7326/0003-4819-93-2-275. [DOI] [PubMed] [Google Scholar]
  7. Paterson C. R., Naismith K. I., Young J. A. Severe unexplained hypophosphatemia. Clin Chem. 1992 Jan;38(1):104–107. [PubMed] [Google Scholar]
  8. Rasmussen H., Pechet M., Anast C., Mazur A., Gertner J., Broadus A. E. Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3. J Pediatr. 1981 Jul;99(1):16–25. doi: 10.1016/s0022-3476(81)80951-1. [DOI] [PubMed] [Google Scholar]
  9. Seshadri M. S., Cornish C. J., Mason R. S., Posen S. Parathyroid hormone-like bioactivity in tumours from patients with oncogenic osteomalacia. Clin Endocrinol (Oxf) 1985 Dec;23(6):689–697. doi: 10.1111/j.1365-2265.1985.tb01130.x. [DOI] [PubMed] [Google Scholar]
  10. Sweet R. A., Males J. L., Hamstra A. J., DeLuca H. F. Vitamin D metabolite levels in oncogenic osteomalacia. Ann Intern Med. 1980 Aug;93(2):279–280. doi: 10.7326/0003-4819-93-2-279. [DOI] [PubMed] [Google Scholar]
  11. Taylor H. C., Fallon M. D., Velasco M. E. Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma. Ann Intern Med. 1984 Dec;101(6):786–788. doi: 10.7326/0003-4819-101-6-786. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES